Tag Archives: Biotech

Biotech is busting out, but trader says this corner of health care is better bet

There’s a burgeoning breakout in one corner of health care. The IBB biotech ETF has surged 6% over the past week, roughly triple the gains on the broader XLV health care ETF. Ari Wald, head of technical analysis at Oppenheimer, expects the group to continue to grind higher. The IBB “had been in this narrowing… Read More »